TARA short interest
Protara Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 5,791,421 |
|---|---|
| Change vs prior report | 1,374,326 (+31.1%) |
| Change over six months | +4.3% |
| Days to cover | 2.91 (sector: 3.78) |
| Average daily volume | 1,992,294 |
| Rank in Healthcare | #639 of 922 by days to cover |
TARA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 5,791,421 | +31.1% | 2.91 | 1,992,294 |
| 2026-09-15 | 4,417,095 | -0.3% | 10.34 | 427,229 |
| 2026-08-31 | 4,431,963 | -2.4% | 12.36 | 358,569 |
| 2026-08-14 | 4,541,333 | +1.0% | 12.03 | 377,534 |
| 2026-07-31 | 4,495,001 | -1.0% | 11.47 | 392,044 |
| 2026-07-15 | 4,541,891 | +4.8% | 6.72 | 676,262 |
| 2026-06-30 | 4,335,683 | -2.9% | 5.12 | 847,363 |
| 2026-06-15 | 4,465,466 | -24.2% | 6.55 | 682,189 |
| 2026-05-29 | 5,888,171 | +57.5% | 6.17 | 953,737 |
| 2026-05-15 | 3,739,353 | -37.6% | 5.61 | 665,961 |
| 2026-04-30 | 5,995,936 | +4.4% | 9.57 | 626,439 |
| 2026-04-15 | 5,745,340 | +3.5% | 11.15 | 515,484 |
| 2026-03-31 | 5,550,159 | -13.3% | 6.14 | 903,792 |
| 2026-03-13 | 6,399,060 | +30.7% | 6.19 | 1,033,650 |
| 2026-02-27 | 4,895,488 | +48.0% | 3.08 | 1,590,962 |
| 2026-02-13 | 3,308,046 | +16.8% | 6.15 | 537,607 |
| 2026-01-30 | 2,832,933 | +12.3% | 2.34 | 1,209,683 |
| 2026-01-15 | 2,521,732 | +14.7% | 2.06 | 1,223,590 |
| 2025-12-31 | 2,198,324 | -15.5% | 3.95 | 555,983 |
| 2025-12-15 | 2,602,314 | -10.5% | 1.68 | 1,550,119 |
| 2025-11-28 | 2,908,827 | +4.8% | 3.12 | 933,707 |
| 2025-11-14 | 2,774,733 | -1.8% | 6.51 | 426,238 |
| 2025-10-31 | 2,825,459 | -1.0% | 8.27 | 341,518 |
| 2025-10-15 | 2,855,093 | +16.0% | 4.50 | 634,842 |
| 2025-09-30 | 2,461,167 | -8.6% | 2.51 | 981,541 |
import finzdata as yf
yf.Ticker("TARA").short_interest # every report since 2017
yf.Client().short_interest(["TARA"], start="2018-01-01")Healthcare short interest · TARA price history · Who owns TARA · All short interest